Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-19T01:40:29.875Z Has data issue: false hasContentIssue false

Infectious disease physician characteristics and prescription of meropenem in the hospital

Published online by Cambridge University Press:  17 July 2023

Douglas Challener*
Affiliation:
Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USA
John O’Horo
Affiliation:
Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USADivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
Aaron J. Tande*
Affiliation:
Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USA
*
Corresponding author: Douglas Challener; Email: Challener.Douglas@mayo.edu
Co-corresponding author: Aaron J. Tande; Email: tande.aaron@mayo.edu

Abstract

Objective:

Physician characteristics may be correlated with medical treatment decisions and patient outcomes. This study examined the correlations between characteristics of infectious disease (ID) physicians and the use of the restricted antimicrobial meropenem.

Design:

This was a retrospective cohort study following 27 attending ID physicians for 5 years at a large academic medical center.

Methods:

All inpatient ID clinical encounters between 2013 and 2018 were assessed for physician and patient characteristics, including patient Charlson Comorbidity Index, patient sex, ID service seeing the patient, physician career stage, physician training location, and physician sex. Adjusted and unadjusted odds ratios were calculated for the receipt of meropenem on the same day as an ID clinical note.

Results:

Between 2013 and 2018, meropenem was administered on the same day as 9046 (11.1%) of 81,787 inpatient ID encounters. After adjustment for patient and practice-specific factors, physician career stage was associated with administration of meropenem. Patients seen by mid-career and late-career ID physicians were more likely to receive meropenem than those seen by early-career physicians (aOR 1.22 95% confidence interval [CI 1.13–1.31 and aOR 1.17 95% CI 1.10–1.25, respectively).

Conclusions:

ID provider characteristics may help target future antimicrobial stewardship program interventions.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Odds of meropenem administration by patient and physician characteristics

Supplementary material: File

Challener et al. supplementary material

Table S2

Download Challener et al. supplementary material(File)
File 13.9 KB
Supplementary material: File

Challener et al. supplementary material

Table S1

Download Challener et al. supplementary material(File)
File 18.7 KB